Efficacy of inactivated poliovirus vaccine in India

Science

Volumn 345, Issue 6199, 2014, Pages 922-925

  Jafari, Hamid ^a   Deshpande, Jagadish M ^b   Sutter, Roland W ^a   Bahl, Sunil ^a   Verma, Harish ^a   Ahmad, Mohammad ^a   Kunwar, Abhishek ^a   Vishwakarma, Rakesh ^a   Agarwal, Ashutosh ^a   Jain, Shilpi ^c   Estivariz, Concepcion ^d   Sethi, Raman ^a   Molodecky, Natalie A ^a   Grassly, Nicholas C ^e   Pallansch, Mark A ^d   Chatterjee, Arani ^c,f   Aylward, R Bruce ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Haffkine Institute for Training Research and Testing India   (India)

^c Panacea Biotec Ltd   (India)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f Biological e Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ERADICATION; FECES; FEMALE; HUMAN; IMMUNIZATION; IMMUNOLOGY; INDIA; INFANT; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MUCOSAL IMMUNITY; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; VIROLOGY; VIRUS SHEDDING;

ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DISEASE ERADICATION; FECES; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; INDIA; INFANT; INTESTINAL MUCOSA; MALE; MIDDLE AGED; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; PREVALENCE; VIRUS SHEDDING;

EID: 84906674806     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1255006     Document Type: Article

References (35)

1. R. W. Sutter et al., in Vaccines, S. A. Plotkin, W. A. Orenstein, Eds. (Saunders, Philadelphia, PA, ed. 6, 2012), vol. 28, p. 598.
2. J. R. Paul, History of Poliomyelitis (Yale Univ. Press, Princeton, NJ, 1978.
3. World Health Organization, World Health Assembly (WHA) resolution, 1988 (resolution 41.28).
4. H. F. Hull, N. A. Ward, B. P. Hull, J. B. Milstien, C. de Quadros, Lancet 343, 1331-1337 (1994).
5. World Health Organization, Wkly. Epidemiol. Rec. 88, 153-160 (2013).
6. Centers for Disease Control and Prevention, Morb. Mortal. Wkly. Rep. 50, 222-224 (2001).
7. World Health Organization, Wkly. Epidemiol. Rec. 88, 385-388 (2013).
8. World Health Organization, Wkly. Epidemiol. Rec. 87, 381-388 (2012).
9. World Health Organization, Wkly. Epidemiol. Rec. 88, 349-355 (2013).
10. S. Arie, BMJ 347, f6682 (2013).
11. T. J. John, P. Jayabal, Am. J. Epidemiol. 96, 263-269 (1972).
12. N. C. Grassly et al., Science 314, 1150-1153 (2006).
13. N. C. Grassly et al., J. Infect. Dis. 205, 1554-1561 (2012).
14. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine, J. Infect. Dis. 171, 1097-1106 (1995).
15. N. C. Grassly et al., J. Infect. Dis. 200, 794- 801 (2009).
16. N. El-Sayed et al., N. Engl. J. Med. 359, 1655-1665 (2008).
17. R. W. Sutter et al., Lancet 376, 1682-1688 (2010).
18. B. J. Morinière et al., Lancet 341, 1545-1550 (1993).
19. R. W. Sutter et al., N. Engl. J. Med. 343, 767-773 (2000).
20. C. F. Estívariz et al., Lancet Infect. Dis. 12, 128-135 (2012).
21. S. E. Robertson et al., Lancet 331, 897-899 (1988).
22. T. Francis Jr., J. Am. Med. Assoc. 158, 1266-1270 (1955).
23. T. R. Hird, N. C. Grassly, PLOS Pathog. 8, e1002599 (2012). v
24. E. Anis et al., Euro Surveill. 18, 20586 (2013).
25. The Cuba IPV Study Collaborative Group, N. Engl. J. Med. 356, 1536-1544 (2007).
26. L. Piirainen et al., Vaccine 17, 1084-1090 (1999).
27. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines, J. Infect. Dis. 175 (suppl. 1), S215-S227 (1997).
28. I. Parent. du Châtelet et al., Vaccine 21, 1710-1718 (2003).
29. T. M. Herremans, J. H. Reimerink, A. M. Buisman, T. G. Kimman, M. P. Koopmans, J. Immunol. 162, 5011-5018 (1999).
30. T. Herremans et al., Clin. Infect. Dis. 34, 1067-1075 (2002).
31. R. D. Puligedda et al., Antiviral Res. 108, 36-43 (2014).
32. World Health Organization, Wkly. Epidemiol. Rec. 88, 1-6 (2013).
33. S. Resik et al., N. Engl. J. Med. 368, 416-424 (2013).
34. World Health Organization, WHO, Geneva (WHO/POL/13.02) (2013).
35. World Health Organization, Wkly. Epidemiol. Rec. 89, 73-92 (2014).